viewOptiBiotix Health PLC

OptiBiotix Health CEO discusses recent big deals and its focus on profitability

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara caught up with Proactive London's Andrew Scott after announcing they've signed a one-year deal with Lebanon-based Prosperous Pharma - a pharmaceutical distributor that also supplies nutraceuticals to doctors, pharmacies and consumers.

It will have exclusive rights over OptiBiotix's SlimBiome Medical for the Gulf Cooperation Council States and the Levant.

O'Hara also recaps on a number of recent deals they've done including an agreement with Velinoff Pharma as well as the modified agreement with partner Sacco for its LPLDL cholesterol-lowering additive which has been extended out to 2023.

''These deals are all part of the next stage of the business cycle .... the focus now is on profitability''.

Quick facts: OptiBiotix Health PLC

Price: 66.5 GBX

Market: AIM
Market Cap: £58.48 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...



OptiBiotix Health CEO talks significant new China, Hong Kong and North...

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara speaks to Proactive's Andrew Scott after entering into a three-year distribution agreement with Asian product developer and distributor, Pierce Group. This week they've also agreed a non-exclusive license deal for its SlimBiome trademark with...

3 weeks, 1 day ago

2 min read